Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financi...(29438245 PROPERTY AND EQUIPMENT - Net...),Health

Date:4/22/2009

29,438,245 PROPERTY AND EQUIPMENT - Net 7,554,817 6,169,966 OTHER ASSETS Deposit on patent license 2,917,919 -- Installments on intangible assets 38,175,134 -- Intangible assets, net of accumulated amortization 1,231,730 1,291,322 Deferred debt costs 66,344 -- Total Assets $63,708,518 $36,899,533 LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES: Convertible debt, net of debt discount $-- $2,561,645 Accounts payable and accrued expenses 2,170,165 764,491 Taxes Payable 5,015,908 572,200 Advances from customers -- 34,531 Unearned revenue 565,629 530,063 Due to related parties 1,588,689 323,178 Total Current Liabilities 9,340,391 4,786,108 LONG-TERM LIABILITIES: Due to related parties 525,225 738,300 Notes payable - related parties 5,056,451 4,738,508 Series A convertible redeemable preferred stock, $.001 par value; 10,000,000 shares authorized; 5,747,118 and -0- shares issued and outstanding at December 31, 2008 and 2007, respectively, net 3,652,341 -- Total Liabilities 18,574,408 10,262,916 SHAREHOLDERS' EQUITY: Common stock ($.001 par value; 200,000,000 shares authorized; 42,420,239 and 41,794,200 shares issued and outsta
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13
Related medicine news :

1. iEnterprises Launches iComply, Lotus Notes Email Archiving and Compliance Software
2. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
3. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
4. Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
5. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
6. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
7. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
8. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
9. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
10. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
11. Lotus Pharmaceuticals Raises $5 Million in Private Placement